Nitrogen Containing Compound Utilized (e.g., Pyridine, Carbamates, Urea, Etc., Utilized As Catalysts, Proton Acceptors, Etc.) Patents (Class 558/101)
  • Publication number: 20130158283
    Abstract: Novel synthetic routes, which are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids are disclosed. Particularly, novel methods for efficiently preparing compounds having a glycerolic backbone and one or more oxidized moieties attached to the glycerolic backbone, which are devoid of column chromatography are disclosed. Further disclosed are novel methods of introducing phosphorous-containing moieties such as phosphate moieties to compounds having glycerolic backbone and intermediates formed thereby.
    Type: Application
    Filed: December 10, 2012
    Publication date: June 20, 2013
    Applicant: Vascular Biogenics Ltd.
    Inventor: Vascular Biogenics Ltd.
  • Publication number: 20120172613
    Abstract: Phosphate ester compounds are prepared by reacting phosphoryl chloride with at least one mono(alkylene glycol) monoether or poly(alkylene glycol) monoether, or a mixture at least one mono(alkylene glycol) monoether or poly(alkylene glycol) monoether and at least one alkylene glycol or polyalkylene glycol, in the presence of at least three moles per mole of phosphoryl chloride of a pyridinyl compound that is devoid of aliphatic nitrogen atoms.
    Type: Application
    Filed: September 24, 2010
    Publication date: July 5, 2012
    Applicant: Dow Technologies LLC
    Inventor: Nicole L. Wagner
  • Publication number: 20120130108
    Abstract: Novel synthetic routes, which are highly applicable for industrial preparation of therapeutically beneficial oxidized phospholipids are disclosed. Particularly, novel methods for efficiently preparing compounds having a glycerolic backbone and one or more oxidized moieties attached to the glycerolic backbone, which are devoid of column chromatography are disclosed. Further disclosed are novel methods of introducing phosphorous-containing moieties such as phosphate moieties to compounds having glycerolic backbone and intermediates formed thereby.
    Type: Application
    Filed: January 26, 2012
    Publication date: May 24, 2012
    Applicant: Vascular Biogenics Ltd.
    Inventors: Gideon Halperin, Eti Kovalevski-Ishai
  • Patent number: 8097749
    Abstract: The present invention relates to a process for preparation of a phosphoromonochloridite in high yield by contacting phosphorus trichloride (PCl3) with an aromatic diol in a solution of one or more organic solvents under reaction conditions sufficient to produce the phosphoromonochloridite. The reaction is carried out by adding a feed solution containing the aromatic diol dissolved in a first organic solvent into a reaction zone containing PCl3, and optionally one or more second organic solvents, the addition being conducted so as to maintain substantially isothermal process conditions. The reaction solution comprises greater than 0.01 to less than 5 mole percent of a nitrogen base.
    Type: Grant
    Filed: March 17, 2009
    Date of Patent: January 17, 2012
    Inventor: Glenn A. Miller
  • Publication number: 20110059923
    Abstract: The present invention relates to a novel {4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders which contains the same as an active component. The novel {4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate or a pharmaceutically acceptable salt thereof according to the present invention can beneficially be used to prevent and treat central nervous system disorders since it exhibits an equivalent biological and pharmacological activity to venlafaxine and salts thereof which are known in the field, it has very little toxicity, and, in particular, it is outstandingly soluble in water as compared with prior-art venlafaxine derivatives.
    Type: Application
    Filed: May 8, 2009
    Publication date: March 10, 2011
    Applicant: JE IL PHARMACEUTICAL CO., LTD.
    Inventors: Seok Won Kang, Jong Soo Chun, Heung Mo Kang, Eui Seok Hong, Kwang-Woo Chun, Young Seok Byun, Myung-Hwa Kim, Young II Moon, Jei Man Ryu
  • Publication number: 20100298506
    Abstract: The present invention relates to a method for producing an amino group-containing phosphate compound, by which the compound can be easily synthesized through a one-step reaction. The method for producing an amino group-containing phosphate compound comprises reacting an aminophenol compound represented by the general formula (1) with a dichlorophosphoric acid compound represented by the general formula (2): (where X1, X2, X3, X4 and X5 each represent a hydrogen atom or an alkyl group having 1 to 3 carbon atoms) in the presence of an inorganic basic compound in an aprotic organic solvent, to obtain a amino group-containing phosphate compound represented by the following general formula (3) where X1, X2, X3, X4 and X5 are defined in the same way as in the general formula (2).
    Type: Application
    Filed: June 9, 2006
    Publication date: November 25, 2010
    Applicant: SHOWA HIGHPOLYMER CO., LTD.
    Inventors: Hirotoshi Kamata, Kentarou Takahashi, Hui Li, Boris Ionin
  • Patent number: 5527939
    Abstract: Disclosed herein is an improved process for preparing a phosphorodihalodithioate comprising reacting a mercaptan with a thiophorphoryl halide in the presence of a catalyst, the improvement comprising a catalytic amount of a tertiary amine catalyst.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: June 18, 1996
    Assignee: Bayer Corporation
    Inventors: Vidyanatha A. Prasad, Peter E. Newallis
  • Patent number: 5245069
    Abstract: This invention relates to a novel process for preparing bis(aryl)phosphorohalidates which are useful in the synthesis of various enol phosphates. The process of this invention provides a means of producing a high-yield, high-purity product without the need for costly crystallization or impractical, high temperature distillations.
    Type: Grant
    Filed: October 27, 1992
    Date of Patent: September 14, 1993
    Assignee: Merck & Co., Inc.
    Inventor: James W. McManus
  • Patent number: 5097516
    Abstract: To obtain an enhanced two-dimensional image of a raised, light-reflective reflective feature (12), and its lower height surrounding background such that the contrast between them is enhanced, a line of light having a gradient profile is directed at an acute angle at the feature and its background to illuminate a strip of area thereacross. The reflectance intensity of the illuminated strip will vary in accordance with the height thereof because of the gradient intensity profile of the line of light. When the line of light is spanned across the feature and its background, the resultant image of the feature and its background, captured by spanning a linescan camera (24) thereacross, will exhibit an enhanced contrast between the feature and its background because of the greater height of the feature.
    Type: Grant
    Filed: February 28, 1991
    Date of Patent: March 17, 1992
    Assignee: AT&T Bell Laboratories
    Inventor: Israel Amir
  • Patent number: 4956487
    Abstract: Thiophosphonate compounds having the formula ##STR1## in which R is alkyl, haloalkyl or aryl; X is chloro or SR.sub.2 ; R.sub.1 is alkyl or aryl; and when X is SR.sub.2 then R.sub.2 is a group identical to R.sub.1, or R.sub.1 and R.sub.2 taken together form an optionally alkyl-substituted polymethylene group, are prepared by reaction of a thiophosphonodichloride with a mercaptan in the presence of a catalytic amount of a quaternary ammonium or phosphonium salt, a tertiary amine or hydrohalide thereof or an alkali metal halide combined with a Crown ether, in the substantial absence of a base.
    Type: Grant
    Filed: December 12, 1988
    Date of Patent: September 11, 1990
    Assignee: ICI Americas Inc.
    Inventors: Jeffrey D. Robbins, Richard D. Gless, Jr.
  • Patent number: 4845261
    Abstract: This invention relates to a novel process for preparing bis(substituted phenyl) phosphorohalidates.
    Type: Grant
    Filed: May 11, 1987
    Date of Patent: July 4, 1989
    Assignee: Merck & Co., Inc.
    Inventor: Lelia M. Fuentes